On May 26, Health Minister Marjorie Michel announced the launch of the new Canadian Drug Analysis Centre (CDAC). The centre will generate forensic intelligence to help law enforcement disrupt Canada’s illegal drug market.
The move comes as Canada continues to grapple with a toxic drug supply linked to more than 7,000 opioid-related deaths a year.
“The CDAC will strengthen our ability to analyze drug samples and help us better understand where drugs are produced and how they are distributed,” Michel said at a media briefing in Scarborough, Ont.
The new centre is located in Scarborough, while a second lab will be based in Vancouver.
Health Canada already conducts drug sample analysis through its Drug Analysis Service, which operates laboratories across Canada and analyzes more than 100,000 samples a year, submitted primarily by law enforcement partners.
The new centre builds on this existing capacity with a focus on intelligence for law enforcement, according to Michel.
“The goal is to [conduct] in‑depth analysis on any chemicals that are used … to find some impurities or byproducts or markers that will allow law enforcement to make some links between production site origin or even some different country,” said Benoit Archambault, acting director general of Health Canada’s Regulatory Operations and Enforcement Branch Laboratories.
Synthetic drugs are increasingly being manufactured domestically, driven in part by access to precursor chemicals used in the drugs’ production.
In 2024, RCMP dismantled a fentanyl “superlab” in British Columbia where precursor chemicals were used to produce roughly 54 kilograms of fentanyl. For context, even a few milligrams of fentanyl can be lethal.
Harm reduction and enforcement
The centre’s launch highlights a separation between enforcement-focused drug analysis and harm-reduction drug checking services.
Harm-reduction drug checking services such as the Toronto Drug Checking Service analyze substances submitted by people who use drugs. The results are shared in public health alerts to reduce overdose risks.
The new drug analysis centre, by contrast, will analyze substances seized by Canada Border Services Agency, the RCMP, and provincial and municipal police services across the country.
“The CDAC provides a new tool to support law enforcement and enable deeper collaboration with partners to protect communities from illegal drugs,” said Michel.
Collaboration with Toronto Drug Checking Service is “not the goal,” Archambault told Canadian Affairs during the question period following the briefing.
Karen McDonald, lead of Toronto’s Drug Checking Service, told Canadian Affairs that the positioning of the new centre “makes a lot of sense.”
“This is in line with their security and public safety priorities,” she said. “This is not about harm reduction … and I do think the distinction is very important.”
McDonald said a separation between drug checking services and enforcement-focused drug analysis is necessary to ensure user trust.
“Our program only works because people who use drugs trust us,” she said.
“If suddenly it seemed as though we were closely collaborating with law enforcement or informing law enforcement efforts, that would not bode well for our program, because it is likely that people who use drugs would stop donating samples to us.”
But she noted the Toronto Drug Checking Service and Health Canada do collaborate.
“We have quite a lot of opportunities to collaborate … [including] meeting with various different departments within Health Canada, presenting our work and talking about it,” said McDonald.
“We rely on each other’s data sources.”
Canadian Affairs previously reported that Toronto’s Drug Checking Service provides real-time, community-based monitoring of the unregulated drug supply. This can enable it to flag new, toxic drugs before they appear in provincial or federal surveillance systems.
“If we really want to understand what’s happening with the drug supply, it’s important that we’re monitoring what’s happening across programs,” said McDonald.
